Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 176,026 | 180,193 | 172,637 | 156,040 | 151,194 |
| Cost of Goods | 106,629 | 105,572 | 103,809 | 96,434 | 94,702 |
| Gross Profit | 69,397 | 74,621 | 68,828 | 59,606 | 56,492 |
| Operating Expenses | 26,652 | 30,990 | 30,120 | 24,597 | 22,938 |
| Operating Income | 43,374 | 44,203 | 39,517 | 35,443 | 34,256 |
| Interest Expense | 2,073 | 2,119 | 2,116 | 2,097 | 2,173 |
| Other Income | 766 | 736 | 901 | 752 | 478 |
| Pre-tax Income | 42,067 | 42,820 | 38,302 | 34,098 | 32,561 |
| Income Tax | 15,775 | 16,058 | 20,152 | 13,128 | 12,536 |
| Net Income Continuous | 25,821 | 26,300 | 17,594 | 20,645 | 19,591 |
| Net Income | $25,821 | $26,300 | $17,594 | $20,645 | $19,591 |
| EPS Basic Total Ops | 0.56 | 0.57 | 0.38 | 0.45 | 0.43 |
| EPS Basic Continuous Ops | 0.56 | 0.57 | 0.38 | 0.45 | 0.43 |
| EPS Diluted Total Ops | 0.51 | 0.52 | 0.36 | 0.42 | 0.40 |
| EPS Diluted Continuous Ops | 0.49 | 0.50 | 0.34 | 0.40 | 0.38 |
| EBITDA(a) | $51,857 | $52,342 | $47,697 | $44,282 | $41,906 |